Wolfe Research downgraded Exact Sciences (EXAS) to Peer Perform from Outperform after Abbott (ABT) announced an agreement to acquire Exact for $105 per share in cash.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXAS: